SU Medical Limited - Accounts to registrar (filleted) - small 23.2.5

REGISTERED NUMBER: 08623058 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 July 2023

for

SU Medical Limited

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr S A Kim

Dr J Kim

REGISTERED OFFICE:

3A Evolution

Wynyard Business Park

Wynyard

Billingham

TS22 5TB

REGISTERED NUMBER:

08623058 (England and Wales)

ACCOUNTANTS:

Flannagans - Hartlepool Office

Chartered Certified Accountants

3A Evolution

Wynyard Business Park

Wynyard

Billingham

TS22 5TB

FIXED ASSETS

Intangible assets

4

117,027

117,027

Tangible assets

5

3,866

40,500

120,893

157,527

CURRENT ASSETS

Debtors

428,576

273,459

Cash at bank

74,611

168,062

503,187

441,521

CREDITORS

Amounts falling due within one year

60,623

90,115

NET CURRENT ASSETS

442,564

351,406

TOTAL ASSETS LESS CURRENT LIABILITIES

563,457

508,933

CREDITORS

Amounts falling due after more than one year

-

(38,870

)

PROVISIONS FOR LIABILITIES

-

(8,241

)

NET ASSETS

563,457

461,822

CAPITAL AND RESERVES

Called up share capital

101

101

Retained earnings

563,356

461,721

563,457

461,822

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 July 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 November 2023 and were signed on its behalf by:

Dr J Kim - Director

1.	STATUTORY INFORMATION

SU Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4.	INTANGIBLE FIXED ASSETS

Totals

£

COST

At 1 August 2022

and 31 July 2023

117,027

NET BOOK VALUE

At 31 July 2023

117,027

At 31 July 2022

117,027

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 August 2022

80,732

Disposals

(65,285

)

At 31 July 2023

15,447

DEPRECIATION

At 1 August 2022

40,232

Charge for year

2,971

Eliminated on disposal

(31,622

)

At 31 July 2023

11,581

NET BOOK VALUE

At 31 July 2023

3,866

At 31 July 2022

40,500